ALZN
Alzamend Neuro, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.71
+0.59%Aug 4, 2026, 12:00 UTC
Alzamend Neuro announced the initial closing of a securities purchase agreement with Ault Lending, receiving $7.5 million in gross proceeds from the sale of Series D Convertible Preferred Stock, with up to $17.5 million in additional funding available through subsequent tranches.
Source: